Liver Cancer Clinical Trial Results

Browse clinical trials for Liver Cancer by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizum
  Phase 2 · MedImmune LLC · Active, not recruiting · Dec 6, 2021
• Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Jan 7, 2025
• A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
  Phase 3 · CStone Pharmaceuticals · Active, not recruiting · Jul 30, 2026
• BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
  Phase 1/2 · Edward Kim · Terminated · Aug 22, 2023
• Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinom
  Phase 3 · AstraZeneca · Active, not recruiting · Jun 18, 2023
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wi
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Nov 28, 2022
• Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Apr 15, 2025
• Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
  Phase 2 · Academic and Community Cancer Research United · Active, not recruiting · Jul 20, 2026
• A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
  Phase 2 · Jennerex Biotherapeutics · Completed · Jul 14, 2026
• A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
  Phase 2 · Jennerex Biotherapeutics · Completed · Jul 8, 2026
• A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma
  Phase 2 · David Hsieh · Completed · Jul 17, 2024
• Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
  N/A · University of Alabama at Birmingham · Completed · Jul 2, 2026
• Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080
  Phase 2 · Merck Sharp & Dohme LLC · Completed · Jun 23, 2026
• Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carc
  Phase 1/2 · Imperial College London · Completed · Jun 29, 2026
• mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for
  Phase 2 · OHSU Knight Cancer Institute · Terminated · Jun 25, 2026

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials